Jounce Therapeutics, Inc.: Redx and Jounce Announce Recommended Business Combination
Combined group will have a strong clinical pipeline and proven expertise in the discovery and development of highly selective therapeutics for the treatment of cancer and fibrotic disease RXC007, a next-generation
Source: finanznachrichten.de